Core Mycelia Blend
Natural health product licensed in Canada
- Licence holder
- 1825192 Ontario Limited
- NPN or DIN-HM
- 80044004
- Status
- Inactive licence
- Licence date
- 2 August 2013
- Revision date
- Not provided
- Form
- Liquide oral
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Grifola frondosa Source : Mycelia Extraction ratio : 1:5 Dry plant equivalent : 0.0004 g | 0.002 mL | Not calculated |
| Lentinula edodes Source : Mycelia Extraction ratio : 1:0.005 Dry plant equivalent : 0.4 mg | 0.002 mL | Not calculated |
Non-medicinal ingredients
Saveur de baies, Citrate de sodium dihydraté, Ethanol, Eau purifiée, Feuille de Stevia rebaudiana, Extrait de graine de Pamplemousse, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 35 Goutte(s) | 3 days |
Uses authorised in Canada
A source of antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are taking anticoagulant drugs, hypotensives, or salycilates (ie acetylsalicylic acid/ASA). Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have an auto-immune disorder. Consult a health care practitioner prior to use if you have diabetes or hypoglycaemia. If you are taking immunosuppressants consult a health care practitioner prior to use.
- Effets indésirables connus
Hypersensitivity (ie allergy) is known to occur, in which case discontinue use. If you develop dry mouth, skin rash, drowsiness, nausea or diarrhea discontinue use and consult a health care practitioner. If you develop heartburn, palpitations, constipation, boating, dermatitis chest pain, fever or cold/flu like symptoms discontinue use and consult a health care practitioner. For use beyond 3 months: Dizziness, irritated skin, nausea and diarrhea have been known to occur in which case, discontinue use. If you develop mouth ulcers discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80044004
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.